Full Professor(heuristic)

Lung Cancer Research Studies · Oncology

h-index135
i10-index454
Publications1,701
Citations88,379

Grants

47 total · 17 active

NIH #5R01CA264078-04

Drivers of histologic transformation in EGFR-mutant lung cancer

Expiring Soon
Amount
$385K
Period
2021-09-21 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA264078-03

Drivers of histologic transformation in EGFR-mutant lung cancer

Expiring Soon
Amount
$397K
Period
2021-09-21 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA264078-02

Drivers of histologic transformation in EGFR-mutant lung cancer

Expiring Soon
Amount
$397K
Period
2021-09-21 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

47 total · 17 active

NIH #5R01CA264078-04

Drivers of histologic transformation in EGFR-mutant lung cancer

Expiring Soon
Amount
$385K
Period
2021-09-21 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA264078-03

Drivers of histologic transformation in EGFR-mutant lung cancer

Expiring Soon
Amount
$397K
Period
2021-09-21 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA264078-02

Drivers of histologic transformation in EGFR-mutant lung cancer

Expiring Soon
Amount
$397K
Period
2021-09-21 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #1R01CA264078-01

Drivers of histologic transformation in EGFR-mutant lung cancer

Expiring Soon
Amount
$405K
Period
2021-09-21 → 2026-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #2P30CA008748-60

Cancer Center Support Grant

Active
Amount
$13.1M
Period
1997-01-20 → 2030-12-31
PIs
1
Est. capacity / PI
~28 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R35CA263816-05

Novel therapeutic development for small cell lung cancer

Active
Amount
$1.1M
Period
2021-08-10 → 2028-07-31
PIs
1
Est. capacity / PI
~5 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R35CA263816-04

Novel therapeutic development for small cell lung cancer

Active
Amount
$1.0M
Period
2021-08-10 → 2028-07-31
PIs
1
Est. capacity / PI
~5 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R35CA263816-03

Novel therapeutic development for small cell lung cancer

Active
Amount
$1.0M
Period
2021-08-10 → 2028-07-31
PIs
1
Est. capacity / PI
~5 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R35CA263816-02

Novel therapeutic development for small cell lung cancer

Active
Amount
$1.0M
Period
2021-08-10 → 2028-07-31
PIs
1
Est. capacity / PI
~5 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #1R35CA263816-01

Novel therapeutic development for small cell lung cancer

Active
Amount
$1.1M
Period
2021-08-10 → 2028-07-31
PIs
1
Est. capacity / PI
~5 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA264078-05

Drivers of histologic transformation in EGFR-mutant lung cancer

Active
Amount
$405K
Period
2021-09-21 → 2027-08-31
PIs
2
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5U24CA213274-10

Coordinating center for the NCI small cell lung cancer research consortium

Active
Amount
$1.1M
Period
2022-06-24 → 2027-05-31
PIs
4
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5U24CA213274-09

Coordinating center for the NCI small cell lung cancer research consortium

Active
Amount
$1.4M
Period
2022-06-24 → 2027-05-31
PIs
4
Est. capacity / PI
~1 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5U24CA213274-08

Coordinating center for the NCI small cell lung cancer research consortium

Active
Amount
$1.5M
Period
2022-06-24 → 2027-05-31
PIs
4
Est. capacity / PI
~1 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5U24CA213274-07

Coordinating center for the NCI small cell lung cancer research consortium

Active
Amount
$1.6M
Period
2022-06-24 → 2027-05-31
PIs
4
Est. capacity / PI
~1 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #2U24CA213274-06

Coordinating center for the NCI small cell lung cancer research consortium

Active
Amount
$1.7M
Period
2022-06-24 → 2027-05-31
PIs
4
Est. capacity / PI
~1 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5UG1CA233259-06

ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center

Active
Amount
$683K
Period
2019-03-14 → 2027-02-28
PIs
3
Est. capacity / PI
~0 students

Awarded at EMORY UNIVERSITY

NIH #3UG1CA233259-06S1

ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center

Amount
$683K
Period
2025-01-02 → 2026-02-28
PIs
3
Est. capacity / PI
~0 students

Awarded at EMORY UNIVERSITY

NIH #5UG1CA233259-05

ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center

Amount
$622K
Period
2019-03-14 → 2025-02-28
PIs
3
Est. capacity / PI
~0 students

Awarded at EMORY UNIVERSITY

NIH #5UG1CA233259-04

ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center

Amount
$734K
Period
2019-03-14 → 2025-02-28
PIs
3
Est. capacity / PI
~0 students

Awarded at EMORY UNIVERSITY

NIH #5UG1CA233259-03

ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center

Amount
$742K
Period
2019-03-14 → 2025-02-28
PIs
3
Est. capacity / PI
~0 students

Awarded at EMORY UNIVERSITY

NIH #5UG1CA233259-02

ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center

Amount
$751K
Period
2019-03-14 → 2025-02-28
PIs
3
Est. capacity / PI
~0 students

Awarded at EMORY UNIVERSITY

NIH #1UG1CA233259-01

ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center

Amount
$852K
Period
2019-03-14 → 2025-02-28
PIs
3
Est. capacity / PI
~0 students

Awarded at EMORY UNIVERSITY

NIH #5R01CA213448-05

Immuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zrrovalpituzumab, a DLL3-targeting monoclonal antibody

Amount
$940K
Period
2017-01-01 → 2023-12-31
PIs
2
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #5U24CA213274-05

Coordinating center for the NCI small cell lung cancer research consortium

Amount
$1.1M
Period
2017-02-20 → 2022-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5U24CA213274-04

Coordinating center for the NCI small cell lung cancer research consortium

Amount
$1.3M
Period
2017-02-20 → 2022-01-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5U24CA213274-03

Coordinating center for the NCI small cell lung cancer research consortium

Amount
$1.0M
Period
2017-02-20 → 2022-01-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5U24CA213274-02

Coordinating center for the NCI small cell lung cancer research consortium

Amount
$1.1M
Period
2017-02-20 → 2022-01-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #1U24CA213274-01

Coordinating center for the NCI small cell lung cancer research consortium

Amount
$1.2M
Period
2017-02-20 → 2022-01-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #7R01CA213448-04

Immuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zrrovalpituzumab, a DLL3-targeting monoclonal antibody

Amount
$367K
Period
2017-01-01 → 2021-12-31
PIs
3
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #5R01CA213448-02

Immuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zr-rovalpituzumab, a DLL3-targeting monoclonal antibody

Amount
$700K
Period
2017-01-01 → 2021-12-31
PIs
3
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #1R01CA213448-01

Immuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zr-rovalpituzumab, a DLL3-targeting monoclonal antibody

Amount
$447K
Period
2017-01-01 → 2021-12-31
PIs
4
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA197936-05

Determinants of acquired resistance in small cell lung cancer

Amount
$607K
Period
2016-04-18 → 2021-03-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA197936-04

Determinants of acquired resistance in small cell lung cancer

Amount
$611K
Period
2016-04-18 → 2021-03-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA197936-03

Determinants of acquired resistance in small cell lung cancer

Amount
$620K
Period
2016-04-18 → 2021-03-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA197936-02

Determinants of acquired resistance in small cell lung cancer

Amount
$620K
Period
2016-04-18 → 2021-03-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #1R01CA197936-01A1

Determinants of acquired resistance in small cell lung cancer

Amount
$616K
Period
2016-04-18 → 2021-03-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #3U01CA199215-04S1

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Amount
$463K
Period
2015-08-01 → 2020-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5U01CA199215-04

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Amount
$571K
Period
2015-08-01 → 2020-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5R01CA213448-03

Immuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zr-rovalpituzumab, a DLL3-targeting monoclonal antibody

Amount
$631K
Period
2017-01-01 → 2019-07-31
PIs
3
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5U01CA199215-03

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Amount
$571K
Period
2015-08-01 → 2019-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5U01CA199215-02

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Amount
$571K
Period
2015-08-01 → 2019-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #1U01CA199215-01

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Amount
$571K
Period
2015-08-01 → 2019-07-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SLOAN-KETTERING INST CAN RESEARCH

NIH #5P30CA006973-52

CLINICAL RESEARCH OFFICE

Amount
$614K
Period
— → 2016-04-30
PIs
1
Est. capacity / PI
~10 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #4P30CA006973-53

CLINICAL RESEARCH OFFICE

Amount
$614K
Period
— → —
PIs
1
Est. capacity / PI
~10 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5P30CA006973-51

Protocol Review (CRC)

Amount
$83K
Period
— → —
PIs
1
Est. capacity / PI
~1 students

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #5P30CA006973-50

Protocol Review (CRC)

Amount
$81K
Period
— → —
PIs
1
Est. capacity / PI
~1 students

Awarded at JOHNS HOPKINS UNIVERSITY

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 230
Open author page on OpenAlex →